Although there have been no previous studies on the association between ALB and COPD progression, a meta-analysis including 6 studies demonstrated that severe COVID-19 patients had a higher prevalence of COPD and were significantly associated with decreased ALB levels (21). This evidence concerns the gene ALB and COVID-19.